Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100
Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100. // European Urology Open Science. – URL: https://www.sciencedirect.com/science/article/pii/S2666168326012826?dgcid=rss_sd_all
Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100. European Urology Open Science. https://www.sciencedirect.com/science/article/pii/S2666168326012826?dgcid=rss_sd_all
“Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100.” European Urology Open Science.
@article{article45583,
title = {Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100},
journal = {European Urology Open Science},
url = {https://www.sciencedirect.com/science/article/pii/S2666168326012826?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...